SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Overview Fund Activity
Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

33 hedge funds and large institutions have $5.59M invested in Seelos Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 1 closing their positions.

Holders
33
Holders Change
+7
Holders Change %
+26.92%
% of All Funds
0.75%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
8
Increased
1
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
HVC
1
Healthcare Value Capital
New Jersey
$184K
2
BIP
2
Brandes Investment Partners
California
$64K
3
OAM
3
Oxford Asset Management
United Kingdom
$53K
4
Bank of New York Mellon
4
Bank of New York Mellon
New York
$21K
5
VF
5
Virtu Financial
New York
$21K

Top Sellers

1
AC
1
Armistice Capital
New York
$1.56M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$541K
3
Franklin Resources
3
Franklin Resources
California
$139K
4
FANJ
4
Financial Architects (New Jersey)
New Jersey
$0
5
Citadel Advisors
5
Citadel Advisors
Florida
$22K
Name Market Value Shares Shares
Change 		Shares
Change %
KF
26
Krilogy Financial
Missouri
$0 150 – –
Deutsche Bank
27
Deutsche Bank
Germany
$0 2 – –
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
$0 8 – –
BCM
29
Blume Capital Management
California
$0 3 – –
HI
30
Hudock Inc
Pennsylvania
$0 37 – –
LTFS
31
Ladenburg Thalmann Financial Services
Florida
$0 100 – –
IA
32
IFP Advisors
Florida
$0 6 – –
SIAP
33
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$0 4 – –
ASN
34
Advisory Services Network
Georgia
$0 86 +86 New
1
2